At the inaugural Glioblastoma Tumor Microenvironment Symposium on March 27, national leaders in glioblastoma research explored strategies for advancing models, therapies, and collaboration to accelerate progress against the disease.
Led by Koch Institute faculty member Forest White and Franziska Michor of the Dana-Farber Cancer Institute, the event featured presentations on cellular diversity, treatment resistance, and the INSIGHT proteomics platform.
INSIGHT, developed by Forest White and members of his lab, measures how different treatments affect glioblastoma cells, which tend to spread throughout the brain, and could help improve targeted therapies.
Other speakers, connected to researchers include:
Koch Institute faculty member Stefani Spranger, who discussed the role of dendritic cells in the T cell activation or suppression against tumor cells,
Stanford University Professor of Neurology and Neurological Sciences Michelle Mongje, who presented research on the interaction between the myelin sheath and tumors in pediatric glioblastoma
Mayo Clinic Professor of Radiation Oncology Jann Sarkaria, who shared his latest work on developing improved radiosensitizers that make cancer cells more vulnerable to DNA damage
Read more: https://thetech.com/2025/04/03/koch-gbm-2025